Sugi Predict

Sugi Predict / Compounds / SCHEMBL6495417

SCHEMBL6495417

SCHEMBL6495417

CCOP(=O)(Cc1ccc(NC(=S)Nc2cc(-c3cc4cc(F)c(F)cc4[nH]3)ccc2OC)cc1)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ GAA P10253 2/20 0.39
▸ KCNQ2 O43526 1/20 0.38
▸ MAPT P10636 4/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMO Q99835 1/20 0.35
▸ CCNT1 O60563 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ALOX15 P16050 1/20 0.33
▸ HPSE Q9Y251 1/20 0.33
▸ PYGL P06737 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6494591 0.89 SMO (0.47) ALDH1A1GAAKCNQ2MAPTKDM4E
SCHEMBL6495428 0.85 ALDH1A1 (0.40) ALDH1A1GAAKCNQ2MAPTKDM4E
SCHEMBL6495423 0.83 ALOX15 (0.35) ALDH1A1KCNQ2MAPTKDM4EHTT
SCHEMBL6502530 0.82 KMT2A (0.43) ALDH1A1GAAMAPTKDM4ESMO
SCHEMBL6501118 0.81 MEN1 (0.43) ALDH1A1GAAMAPTKDM4EHTT
SCHEMBL6497604 0.81 MEN1 (0.42) ALDH1A1GAAMAPTKDM4ESMO
SCHEMBL6497598 0.81 MEN1 (0.42) ALDH1A1GAAMAPTKDM4ESMO
SCHEMBL6497601 0.80 SMO (0.40) ALDH1A1GAAKCNQ2MAPTSMO
SCHEMBL6504811 0.78 KMT2A (0.49) ALDH1A1GAAMAPTKDM4ELMNA
SCHEMBL6494226 0.78 SMO (0.41) ALDH1A1GAAMAPTKDM4ESMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6858739-B2 Indole and benzimidazole 15-lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 2005-02-22 — — US claimed
EP-1294686-A2 INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 2003-03-26 — — EP claimed
WO-2001096299-A2 INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-12-20 — — WO claimed
US-6858739-B2 Indole and benzimidazole 15-lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 2005-02-22 — — US disclosed
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors CONNOR DAVID THOMAS (US) 2004-02-26 — — US disclosed
EP-1294686-A2 INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 2003-03-26 — — EP disclosed
WO-2001096299-A2 INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-12-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors ALOX15, ALOX5, ALOX12 ALDH1A1 470/4885GAA 3535/4885KCNQ2 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.